Abstract
Purpose: The purpose of this study was to determine the effects of β-glucan and the ability of β-glucan to reduce distal necrosis in a random skin flap in the rat.
Materials and Methods: The present study utilised 14 adult female Wistar rats distributed at random into two groups of seven animals. Group A was set as the control group, in which the subjects received only water and food. In group B, subjects daily received β-glucan (200 mg/kg/day) per oral, starting 5 days prior to surgery, and continued until the second postoperative day. Random pattern skin flaps were cut and sutured on the back of the animals. On the seventh postoperative day, the percentage of distal necrosis was determined and skin samples 2 and 5 cm from the wound were collected in order to determine malondialdehyde levels and for histopathological examinations.
Results: The mean necrotic areas in the control and β-glucan groups were 3.91±1.38 cm2 and 1.13±0.88 cm2, respectively (p<0.001). Malondialdehyde levels were lower in skin samples which were collected from the control group as compared to samples obtained from β-glucan rats (2 cm in the control group, 2.5±1.13; 5 cm in the control group, 2.7±2.19; 2 cm in the β-glucan group 0.9±0.56; 5 cm in the β-glucan group, 1.2±1.07; 2 and 5 cm, p<0.02 and p<0.123, respectively). Histopathologically, a significant increase in macrophage and fibroblast activity was observed in the β-glucan group. The histopathological evaluation in the β-glucan group revealed the protective effects of this intervention. β-Glucan treated rats showed decreased skin flap necrosis when compared with untreated animals.
Conclusion: This study revealed the importance of β-glucan for random skin flap viability.
Keywords:
β-Glucan, rat, flap, necrosis
References
1Pang CY, Forrest CR, Morris SF. Pharmacological augmentation of skin flap viability: a hypothesis to mimic the surgical delay phenomenon or a wishful thought. Ann Plast Surg 1989; 22: 293-306. doi.org/10.1097/00000637-198904000-00003
2Nichter LS, Sobieski MW, Edgerton MT. Augmentation of critical skin flap survival following ibuprofen therapy. Ann Plast Surg 1986; 16: 305-312. doi:10.1097/00000637-198604000-00006
3Israeli D, Senderoff DM, Zhang WX, et al. Enhancement of fluorescein perfusion in experimental skin flaps following postischemic washout with iloprost, urokinase, verapamil, and University of Wisconsin solution. J Reconstr Microsurg 1993; 9: 435-439. doi:10.1055/s-2007-1006753
4Abla LE, Gomes HC, Percario S, et al. Acetylcysteine in random skin flap in rats. Acta Cir Bras 2005; 20: 121-123. doi:10.1590/S0102-86502005000200004 5 Di Luzio NR, Williams DL, McNamee RB, et al. Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate glucan. Recent Results Cancer Res 1980; 75: 165-172. doi.org/10.1007/978-3-642-81491-4_26
5Abel G, Czop JK. Stimulation of human monocyte beta-glucan receptors by glucan particles induces production of TNF-alpha and IL-1 beta. Int J Immunopharmacol 1992; 14: 1363-1373. doi.org/10.1016/0192-0561(92)90007-8
6Doita M, Rasmussen LT, Seljelid R, et al. Effect of soluble aminated beta-1,3-D-polyglucose on human monocytes: stimulation of cytokine and prostaglandin E2 production but not antigen-presenting function. J Leukoc Biol 1991; 49: 342-351.
7Rasmussen LT, Seljelid R. Novel immunomodulators with pronounced in vivo effects caused by stimulation of cytokine release. J Cell Biochem 1991; 46: 60-68. doi:10.1002/jcb.240460110
8Di Luzio NR, Williams DL. Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect Immun. 1978; 20: 804-810.
9Williams DL, Cook JA, Hoffmann EO, et al. Protective effect of glucan in experimentally induced candidiasis. J Reticuloendothel Soc 1978; 23: 479-490.
10Williams DL, Di Luzio NR. Glucan-induced modification of murine viral hepatitis. Science 1980; 208: 67-69. doi:10.1126/science.7361108
11Lee SB, Jeon HW, Lee YW, et al. Bio-artificial skin composed of gelatin and (1-->3), (1-->6)-beta-glucan. Biomaterials 2003; 24: 2503-2511. doi:10.1016/S0142-9612(03)00003-6
12Janusz MJ, Austen KF, Czop JK. Isolation of soluble yeast beta-glucans that inhibit human monocyte phagocytosis mediated by beta-glucan receptors. J Immunol 1986; 137: 3270-3276.
13Kernodle DS, Gates H, Kaiser AB. Prophylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infection. Antimicrob Agents Chemother 1998; 42: 545-549.
14Studley HO. Percentage of weight loss: a basic indicator of surgical risk in patients with chronic peptic ulcer. 1936. Nutr Hosp 2001; 16: 141-143. doi: 10.1001/jama.1936.02770060032009
15Mullen JL, Gertner MH, Buzby GP, et al. Implications of malnutrition in the surgical patient. Arch Surg 1979; 114: 121-125. doi:10.1001/archsurg.1979.01370260011001
16Gross RL, Newberne PM. Role of nutrition in immunologic funtion. Physiol Rev. 1980; 60: 188-302.
17Redmond HP, Leon P, Lieberman MD, et al. Impaired macrophage function in severe protein-energy malnutrition. Arch Surg 1991; 126: 192-196. doi: 10.1001/archsurg.1991.01410260080011
18Babineau TJ, Marcello P, Swails W, et al. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg 1994; 220: 601-609. doi:10.1097/00000658-199411000-00002
19Patchen ML, D'Alesandro MM, Brook I, et al. Glucan: mechanisms involved in its “radioprotective” effect. J Leukoc Biol. 1987; 42: 95-105.
20Portera CA, Love EJ, Memore L, et al. Effect of macrophage stimulation on collagen biosynthesis in the healing wound. Am Surg. 1997; 63: 125-31.
21Wolk M, Danon D. Promotion of wound healing by yeast glucan evaluated on single animals. Med Biol 1985; 63: 73-80.
22Leibovich SJ, Danon D. Promotion of wound repair in mice by application of glucan. J Reticuloendothel Soc 1980; 27: 1-11.
23Delatte SJ, Evans J, Hebra A, et al. Effectiveness of beta-glucan collagen for treatment of partial-thickness burns in children. J Pediatr Surg 2001; 36: 113-118. doi:10.1053/jpsu.2001.20024
24Bhide MV, Dunphy MJ, Mirkopulos N, et al. Promotion of wound collagen formation in normal and diabetic mice by quadrol. Immunopharmacol Immunotoxicol 1988; 10: 513-522. doi:10.3109/08923978809006452
25Wei D, Zhang L, Williams DL, et al. Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor-1 dependent mechanism. Wound Repair Regen 2002; 10: 161-168. doi:10.1046/j.1524-475X.2002.10804.x>
26Hammond DC, Brooksher RD, Mann RJ, et al. The dorsal skin-flap model in the rat: factors influencing survival. Plast Reconstr Surg 1993; 91: 316-321. doi:10.1097/00006534-199302000-00017
27Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-278. doi.org/10.1016/0003-2697(78)90342-1
28Verhofstad MH, Lange WP, van der Laak JA, et al. Microscopic analysis of anastomotic healing in the intestine of normal and diabetic rats. Dis Colon Rectum 2001; 44: 423-431. doi:10.1007/BF02234744
29Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78: 71-100.
30Browder W, Williams D, Lucore P, et al. Effect of enhanced macrophage function on early wound healing. Surgery 1988; 104: 224-230.
31Williams DL, Sherwood ER, McNamee RB, et al. Chemoimmunotherapy of experimental hepatic metastases. Hepatology 1987; 7: 1296-1304. doi:10.1002/hep.1840070620
32Sato T, Iwabuchi K, Nagaoka I, et al. Induction of human neutrophil chemotaxis by Candida albicans-derived beta-1,6-long glycoside side-chain-branched beta-glucan. J Leukoc Biol 2006; 80: 204-211. doi:10.1189/jlb.0106069
33Battle J, Ha T, Li C, et al. Ligand binding to the (1 --> 3)-beta-D-glucan receptor stimulates NFkappaB activation, but not apoptosis in U937 cells. Biochem Biophys Res Commun 1998; 249: 499-504. doi:10.1006/bbrc.1998.9175
